Aurobindo Pharma shatters expectations with record-breaking Q1 FY25 earnings

Pallavi Madhiraju- August 10, 2024

Aurobindo Pharma Limited, a key player in the global pharmaceuticals market, has once again demonstrated remarkable financial health in the first quarter of fiscal year ... Read More

Aurobindo Pharma reports strong growth in Q3FY24 with record sales and EBITDA

Pallavi Madhiraju- February 10, 2024

Aurobindo Pharma Limited, a leading player in the pharmaceutical sector, has announced its consolidated financial results for the quarter ended December 31, 2023. The company ... Read More

Aurobindo Pharma gets tentative FDA approval for generic HIV treatment for children

Pallavi Madhiraju- August 16, 2023

Aurobindo Pharma Limited has achieved a significant milestone by securing the US Food and Drug Administration (FDA)'s tentative nod under the PEPFAR program for its ... Read More

Aurobindo subsidiary gets license to develop and market Nilotinib Capsules in LMICs

Pallavi Madhiraju- June 24, 2023

Aurobindo Pharma, along with its subsidiary Eugia Pharma Specialities has announced a voluntary sub-licensing agreement with Medicines Patent Pool (MPP) to develop and market Nilotinib ... Read More

Aurobindo Pharma gets DCGI nod for Molnupiravir generic version

pallavi123- December 29, 2021

Aurobindo Pharma has secured consent from the Drugs Controller General of India (DCGI) for manufacturing and distributing its generic version of Covid drug Molnupiravir under ... Read More